Mixed
Sarcopenic obesity (high fat mass combined with low muscle mass and function) is a distinct and high-risk phenotype in chronic liver disease (CLD) and IBD, associated with worse prognosis, higher mortality, and increased surgical complications compared to obesity alone or sarcopenia alone.
For people with liver disease or IBD, being obese is risky, but losing muscle makes it much worse. This combination, called 'sarcopenic obesity,' leads to higher death rates and surgery complications. You need to check your muscle mass, not just your weight. If you are losing weight, make sure it's fat, not muscle.
The prognosis was worst in sarcopenic obesity, followed by sarcopenia, normal body composition, and visceral obesity, respectively (p = 0.077)... Patients with sarcopenia had a 3.23 times higher mortality rate compared to non‐sarcopenic patients... Sarcopenia is a common feature of advanced cirrhosis.
Why this rating
Based on observational studies and systematic reviews.
Source
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
Stephan C. Bischoff et al. · United European Gastroenterology Journal · 2022
DOI 10.1002/ueg2.12280
More from this paper
- In patients with inflammatory bowel disease (IBD) and obesity, weight loss therapy should prioritize selective fat mass reduction while preserving lean body mass (muscle) to avoid worsening sarcopenia and surgical risk.Moderate
- Obesity in IBD patients is associated with altered pharmacokinetics of biological therapies, leading to faster drug clearance, lower trough concentrations, and potentially reduced treatment efficacy.Limited
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →